Designing of orally active anti-microbial drug - Meher, Chaitanya Prasad
26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
13 °P sammeln
  • Broschiertes Buch

The aim of the study was to develop new derivative of heterocyclic compound taking orthophenylenediamine as precursor that have better effect and with less side effects using computer aided drug design. As from the literature survey near most all benzimidazole derivative possesses antimicrobial derivative as well as anthelmintic activity, so all the designed derivatives may also possess little to moderate antimicrobial activity as well as anthelmintic activity and most of them follow lipinski's rule so they are orally active drugs having a good pharmacokinetic & pharmacodynamics properties.

Andere Kunden interessierten sich auch für
Produktbeschreibung
The aim of the study was to develop new derivative of heterocyclic compound taking orthophenylenediamine as precursor that have better effect and with less side effects using computer aided drug design. As from the literature survey near most all benzimidazole derivative possesses antimicrobial derivative as well as anthelmintic activity, so all the designed derivatives may also possess little to moderate antimicrobial activity as well as anthelmintic activity and most of them follow lipinski's rule so they are orally active drugs having a good pharmacokinetic & pharmacodynamics properties.
Autorenporträt
El Sr. Chaitanya Prasad Meher, actualmente trabaja como profesor asistente en la Escuela de Farmacia, Universidad Centurión de Tecnología y Gestión, Odisha. Su área de interés para la investigación es CADD y la evaluación de diversas actividades farmacológicas en diferentes extractos de plantas.